{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11758901", "DateCompleted": {"Year": "2002", "Month": "05", "Day": "08"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "10"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0916-8451", "JournalIssue": {"Volume": "65", "Issue": "10", "PubDate": {"Year": "2001", "Month": "Oct"}}, "Title": "Bioscience, biotechnology, and biochemistry", "ISOAbbreviation": "Biosci Biotechnol Biochem"}, "ArticleTitle": "Effects of rooibos tea extract on antigen-specific antibody production and cytokine generation in vitro and in vivo.", "Pagination": {"StartPage": "2137", "EndPage": "2145", "MedlinePgn": "2137-45"}, "Abstract": {"AbstractText": ["Rooibos tea contains a large amount of flavonoids and acts as a potent antioxidant. In this study, we examined the effects of Rooibos tea extract on antigen-specific antibody production and cytokine generation in vitro and in vivo. The primary in vitro anti-ovalbumin (anti-OVA) or sheep red blood cell (SRBC) antibody production in murine splenocytes was markedly stimulated by the addition of the tea extract at concentrations of 1-100 microg/ml. On the other hand, a nonspecific antibody response elicited with lipopolysaccharide (LPS) in purified splenic B-cells was not modified by the extract. Rooibos tea extract caused an increase in the generation of interleukin 2 (IL-2) both in OVA- and anti-CD3-primed splenocytes at concentrations ranging from 10 microg/ml to 1000 microg/ml. In contrast, this tea extract suppressed the generation of interleukin 4 (IL-4) in OVA-primed splenocytes. Moreover, the reduction of OVA-induced antibody production in serum of the cyclosporin A (CyA) -treated rats can be significantly restored and the IL-2 generation in murine splenocytes was stimulated, following oral administrations of Rooibos tea extract. Thus, our findings suggested that Rooibos tea extract may facilitate the antigen-specific antibody production through selective augmentation of IL-2 generation both in vitro and in vivo. Collectively, Rooibos tea intake may be of value in prophylaxis of the diseases involving a severe defect in Th1 immune response such as cancer, allergy, AIDS, and other infections."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunochemistry, Faculty of Pharmaceutical Sciences, Okayama University, Japan."}], "Identifier": [], "LastName": "Kunishiro", "ForeName": "K", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tai", "ForeName": "A", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yamamoto", "ForeName": "I", "Initials": "I"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Biosci Biotechnol Biochem", "NlmUniqueID": "9205717", "ISSNLinking": "0916-8451"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunoglobulin M"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-2"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "207137-56-2", "NameOfSubstance": "Interleukin-4"}, {"RegistryNumber": "9006-59-1", "NameOfSubstance": "Ovalbumin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Antibody Specificity"}, {"QualifierName": ["drug effects", "immunology"], "DescriptorName": "B-Lymphocytes"}, {"QualifierName": [], "DescriptorName": "Beverages"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Immunoglobulin M"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Interleukin-2"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Interleukin-4"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Lipopolysaccharides"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": ["immunology"], "DescriptorName": "Ovalbumin"}, {"QualifierName": ["immunology", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["chemistry"], "DescriptorName": "Rosales"}, {"QualifierName": [], "DescriptorName": "Specific Pathogen-Free Organisms"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2002", "Month": "1", "Day": "5", "Hour": "10", "Minute": "0"}, {"Year": "2002", "Month": "5", "Day": "9", "Hour": "10", "Minute": "1"}, {"Year": "2002", "Month": "1", "Day": "5", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11758901", "10.1271/bbb.65.2137"]}}], "PubmedBookArticle": []}